RU2016111690A - BIOLOGICALLY ACTIVE ADDITIVE FOR PREVENTION OF URINARY DISEASES - Google Patents

BIOLOGICALLY ACTIVE ADDITIVE FOR PREVENTION OF URINARY DISEASES Download PDF

Info

Publication number
RU2016111690A
RU2016111690A RU2016111690A RU2016111690A RU2016111690A RU 2016111690 A RU2016111690 A RU 2016111690A RU 2016111690 A RU2016111690 A RU 2016111690A RU 2016111690 A RU2016111690 A RU 2016111690A RU 2016111690 A RU2016111690 A RU 2016111690A
Authority
RU
Russia
Prior art keywords
prevention
biologically active
active additive
urinary diseases
ascorbic acid
Prior art date
Application number
RU2016111690A
Other languages
Russian (ru)
Other versions
RU2637650C2 (en
Inventor
Дмитрий Михайлович Лазарев
Александр Константинович Овчинников
Татьяна Михайловна Покровская
Original Assignee
Общество с ограниченной ответственностью "ОКТАВА ХОЛДИНГ"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "ОКТАВА ХОЛДИНГ" filed Critical Общество с ограниченной ответственностью "ОКТАВА ХОЛДИНГ"
Priority to RU2016111690A priority Critical patent/RU2637650C2/en
Publication of RU2016111690A publication Critical patent/RU2016111690A/en
Application granted granted Critical
Publication of RU2637650C2 publication Critical patent/RU2637650C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Claims (4)

1. Биологически активная добавка для профилактики заболеваний мочевыводящих путей, содержащая экстракт плодов клюквы (Vaccinium macrocarpon), экстракт листьев толокнянки (Arctostaphylos uva-ursi), аскорбиновую кислоту, отличающаяся тем, что экстракта плодов клюквы содержит проантоцианидины в количестве от 30,600 до 41,400 мг;1. A dietary supplement for the prevention of urinary tract diseases, containing cranberry fruit extract (Vaccinium macrocarpon), bearberry leaf extract (Arctostaphylos uva-ursi), ascorbic acid, characterized in that the cranberry fruit extract contains from 30,600 to 41,400 mg of cranberries; экстракт листьев толокнянки содержит арбутин в количестве от 6,800 до 9,200 мг;bearberry leaf extract contains arbutin in an amount of 6,800 to 9,200 mg; аскорбиновая кислота берется в количестве от 51,000 до 69,000 мг.ascorbic acid is taken in an amount of 51,000 to 69,000 mg. 2. Биологически активная добавка по п. 1, отличающаяся тем, что выполнена в форме саше.2. The dietary supplement according to claim 1, characterized in that it is made in the form of a sachet.
RU2016111690A 2016-03-29 2016-03-29 Composition for prevention of urinary tract diseases RU2637650C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2016111690A RU2637650C2 (en) 2016-03-29 2016-03-29 Composition for prevention of urinary tract diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2016111690A RU2637650C2 (en) 2016-03-29 2016-03-29 Composition for prevention of urinary tract diseases

Publications (2)

Publication Number Publication Date
RU2016111690A true RU2016111690A (en) 2017-10-02
RU2637650C2 RU2637650C2 (en) 2017-12-05

Family

ID=60047526

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016111690A RU2637650C2 (en) 2016-03-29 2016-03-29 Composition for prevention of urinary tract diseases

Country Status (1)

Country Link
RU (1) RU2637650C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202100015446A1 (en) * 2021-06-14 2022-12-14 Nutras S R L Formulation based on Cranberry extract, Uva Ursi, and a third extract

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997029763A1 (en) * 1996-02-14 1997-08-21 The Procter & Gamble Company Urogenital and intestinal disorder compositions comprising a substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor
WO2007144778A2 (en) * 2006-02-22 2007-12-21 Biologic Health Solutions Pty Ltd. Herbal compositions for the prevention or treatment of a urinary tract infection
MX2007006334A (en) * 2007-05-28 2009-02-18 World Trade Imp Export Wtie Ag Pharmaceutical composition comprising the combinaton of an anti-microbial agent and an antioxidant agent for the treatment of urinary infections.
WO2016027226A1 (en) * 2014-08-19 2016-02-25 Kolinpharma S.P.A. A composition for the treatment and prevention of urinary tract infections

Also Published As

Publication number Publication date
RU2637650C2 (en) 2017-12-05

Similar Documents

Publication Publication Date Title
NZ741022A (en) Flavonoid compositions and methods of use
MX2015006193A (en) Composition for dip treatment of plant roots.
WO2011089234A8 (en) Aqueous solution comprising 3-quinuclidinones for the treatment of hyperproliferative, autoimmune and heart disease
PH12016500864A1 (en) Microporous zirconium silicate for the treatment of hyperkalemia
CL2012001985A1 (en) Method for producing a solution containing proanthocyanidin, which comprises providing a mixture of blueberry leaves and an aqueous medium, where the leaves are provided in the mixture at 5-10% w / w; soak the leaves under extraction conditions resulting in a request for proanthocyanidin; separate the blueberry leaves from the solution; solution containing proanthocyanidin; drink containing proanthocyanidin.
WO2013058774A8 (en) Compositions comprising ascorbic acid and an imaging agent and related methods
WO2011081408A3 (en) Imatinib dichloroacetate and anti-cancer agent comprising the same
MX359713B (en) Improved wound healing compositions comprising microspheres.
MY193996A (en) Tripeptide compound, preparation method therefor, and application thereof
RU2016111690A (en) BIOLOGICALLY ACTIVE ADDITIVE FOR PREVENTION OF URINARY DISEASES
WO2008094565A3 (en) Use of abscisic acid combinations for thinning
WO2012027609A3 (en) Extracts from pirin+ and pirin- plants and uses thereof
WO2015075062A3 (en) Method of treating hair
WO2013100718A3 (en) Pharmaceutical composition for preventing or treating inflammatory diseases or asthma, containing lagerstroemia ovalifolia extract or fraction thereof as active ingredient
WO2012155226A8 (en) Method for producing pyrostegia venusta derivatives, pyrostegia venusta derivatives, pharmaceutical compositions and uses thereof
WO2014133811A3 (en) Compounds from invasive salvinias and methods of using the same
RU2013156775A (en) PHARMACEUTICAL COMPOSITION IN THE FORM OF ORAL ORAL SUSPENSION THAT CONTAINS A FLAVONOID FRACTION AND XANTHAN GUM
WO2015167215A3 (en) Hematopoietic composition containing composite medicinal herb extract, and use thereof
WO2015027121A3 (en) Cancer treatment
CN102669197A (en) Drug for controlling apple tree canker
RU2012136782A (en) METHOD FOR PRE-SEED TREATMENT OF SEEDS
CN104382149A (en) Edible mushroom blueberry juice
Rahman et al. Pharmacological profiles of Holarhena antidysenterica (L.) Wall bark
WO2012168049A3 (en) USE OF ε-POLYLYSINE (EPSILON-POLYLYSINE) FOR IMPROVING THE WATERPROOFNESS OF COSMETIC OR DERMATOLOGICAL FORMULATIONS
GB202113860D0 (en) Stable ascorbic acid solution with high water content

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20180330

NF4A Reinstatement of patent

Effective date: 20190701

PC41 Official registration of the transfer of exclusive right

Effective date: 20210923